[Recent findings in the use of 1st and 2nd generation hypoglycemic sulfonamides].
D000328:Adult; D001381:Azepines / Q000008:administration & dosage; D001786:Blood Glucose / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D005947:Glucose / Q000008:administration & dosage; D005951:Glucose Tolerance Test; D005905:Glyburide / Q000008:administration & dosage; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D007328:Insulin / Q000097:blood*; D010080:Oxazoles / Q000008:administration & dosage; D010179:Pancreas / Q000187:drug effects*; D013453:Sulfonylurea Compounds / Q000008:administration & dosage / Q000494:pharmacology*; D014044:Tolbutamide / Q000008:administration & dosage
D001381:Azepines; D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D010080:Oxazoles; D013453:Sulfonylurea Compounds; D014044:Tolbutamide; D005947:Glucose; D005905:Glyburide
Neuere Erkenntnisse bei der Anwendung von blutzuckersenkenden Sulfonamiden der ersten und zweiten Generation.